Gastroenteritis News and Research

RSS

Gastroenteritis (also known as gastro, gastric flu, and stomach flu) refers to inflammation of the gastrointestinal tract, involving both the stomach and the small intestine and resulting in acute diarrhea. The inflammation is caused most often by infection with certain viruses, less often by bacteria or their toxins, parasites, or adverse reaction to something in the diet or medication.

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

Pfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.

12 Mar 2012

MTPC, Medicago partner to develop and commercialize three new vaccines

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the establishment of a strategic alliance with Mitsubishi Tanabe Pharma Corporation (MTPC) through the execution of a Master Research Collaboration Agreement.

6 Mar 2012

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer Inc. issued the following statement in response to today's discussion by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) regarding the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine)in adults 50 years of age and older.

23 Feb 2012

Study identifies norovirus as major cause of all infection outbreaks in U.S. hospitals

Norovirus, a pathogen that often causes food poisoning and gastroenteritis, was responsible for 18.2 percent of all infection outbreaks and 65 percent of ward closures in U.S. hospitals during a two-year period, according to a new study published in the February issue of the American Journal of Infection Control (AJIC), the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

1 Feb 2012

Stimflora launches new dietary health product

An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.

7 Jan 2012

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults

Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the Company's pneumococcal conjugate vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults.

31 Dec 2011

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Pfizer Inc. today announced it has entered into a second supply agreement which will broaden and extend the duration of the Company's commitment to help protect millions of infants and young children in the developing world from pneumococcal disease - the leading cause of vaccine-preventable death in young children.

17 Dec 2011

Single rooms in hospitals is not enough to prevent gastroenteritis

To offer patients single rooms in hospitals is not enough to prevent gastroenteritis. That is shown in a master thesis at Nordic School of Public Health NHV.

13 Dec 2011

Three common scales are not accurate predictors of severe dehydration in children

A physician team from Rhode Island Hospital led a study to evaluate the accuracy of the commonly used dehydration scales as they apply to children in a low-income country. Based on their experience in Rwanda, the researchers determined that none of the three scales were accurate predictors of severe dehydration in children with diarrhea and/or vomiting.

9 Nov 2011

DuoCort Pharma granted marketing authorization for adrenal insufficiency drug, Plenadren in Europe

The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.

7 Nov 2011

Longer looks: A doctor's dilemma on C-sections; apology for a death sparked a hospital's change

I was the obstetrician on hospital duty that Sunday morning, so I introduced myself and learned that the patient, pregnant with her first child, wished to have as few interventions as possible. Respecting her desire, we decided to reevaluate her in a few hours to see how her labor had progressed. But would she get her wish? ... the odds were greater than 1 in 4 that this woman would end up not with the natural delivery she wanted, but with a surgical delivery in one of the two operating rooms down the hall.

4 Nov 2011

New study describes 2010 norovirus outbreak involving several NBA teams

A new study describes a 2010 outbreak involving several NBA teams, the first known report of a norovirus outbreak in a professional sports association. Published in Clinical Infectious Diseases and available online, the study highlights unique circumstances for spreading this highly contagious virus among players and staff on and off the court.

31 Oct 2011

Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA

Pfizer Inc. announced today that additional data from several clinical studies of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) conducted in adults 50 years and older will be presented during the 49th Annual Meeting of the Infectious Diseases Society of America, which is being held Oct. 20-23, 2011, in Boston, Mass.

22 Oct 2011

Gastroenterologist cautions against over-prescription of acid-suppressing drugs in infants

Frequent spitting up, irritability, and unexplained crying in infants can be very distressing to parents. Pediatricians often prescribe acid-suppressing drugs for these symptoms in an effort to treat infants for gastroesophageal reflux disease (GERD); however, GERD is an uncommon cause of these symptoms in otherwise thriving infants.

21 Oct 2011

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

The latest research shows that since the 2006 introduction of routine inoculation against rotavirus -- a leading cause of diarrhea in infants and young children -- almost 65,000 fewer American children have been hospitalized and about $278 million in healthcare costs have been saved.

26 Sep 2011

Vaccinating infants against rotavirus decreases health care use and treatment costs

Vaccinating infants against rotavirus has resulted in dramatic decreases in health care use and treatment costs for diarrhea-related illness in U.S. infants and young children, according to a new study by the Centers for Disease Control and Prevention. The study is published in the current issue of the New England Journal of Medicine.

22 Sep 2011

Gastroenteritis News and Research

Further Reading

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

MTPC, Medicago partner to develop and commercialize three new vaccines

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Study identifies norovirus as major cause of all infection outbreaks in U.S. hospitals

Stimflora launches new dietary health product

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Single rooms in hospitals is not enough to prevent gastroenteritis

Three common scales are not accurate predictors of severe dehydration in children

DuoCort Pharma granted marketing authorization for adrenal insufficiency drug, Plenadren in Europe

Longer looks: A doctor's dilemma on C-sections; apology for a death sparked a hospital's change

New study describes 2010 norovirus outbreak involving several NBA teams

Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA

Gastroenterologist cautions against over-prescription of acid-suppressing drugs in infants

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

Vaccinating infants against rotavirus decreases health care use and treatment costs

Two IGB faculty members recognized as University Scholars

Febrile seizures in children may be linked to respiratory alkalosis

Study finds spread of multidrug-resistant S. Kentucky

FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News